- Business Wire•23 days ago
Aeterna Zentaris Mails Management Information Circular in Connection with Annual Meeting of Shareholders
Aeterna Zentaris Inc. today announced that it has mailed a Notice of Meeting and Management Information Circular to the shareholders of record as of March 20, 2017 in connection with its Annual Meeting of shareholders to be held at the offices of Norton Rose Fulbright Canada, 1 Place Ville-Marie, Suite 2500, in Montreal, Canada on Tuesday, May 9, 2017 at 10:00 a.m.
- MarketWatch•27 days ago
Shares of Aeterna Zentaris Inc. surged almost 14% in premarket trade Thursday, after the biotech said it intends to file a new drug application with the U.S. Food and Drug Administration later this year ...
- Business Wire•27 days ago
Aeterna Zentaris Inc. today announced that, following its meeting with the U.S. Food and Drug Administration on March 29, 2017, the Company intends to file a new drug application seeking approval of Macrilen™ for the evaluation of growth hormone deficiency in adults .
AEZS : Summary for Aeterna Zentaris Inc. - Yahoo Finance
Aeterna Zentaris Inc. (AEZS)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
|Bid||3.10 x 400|
|Ask||3.45 x 500|
|Day's Range||3.10 - 3.20|
|52 Week Range||2.35 - 5.59|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-1.29|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|